Researchers discovered that polio and common cold viruses appear to rely on the same vulnerable mechanism to survive and ...
Porton Advanced, a premier contract development and manufacturing organization (CDMO) specializing in Advanced Therapy Medicinal Products (ATMPs), and Dark Horse Consulting Group ('DHCG' or 'the Group ...
The biotech landscape of 2026 is defined by a convergence of forces that are no longer theoretical but are actively reshaping how drugs are discovered, tested, and approved. From the FDA's formal ...
Madrigal licensed ARO-PNPLA3 from Arrowhead for $25 million upfront and up to $975 million in milestones, expanding a liver-directed siRNA portfolio intended to pair with resmetirom. PNPLA3 silencing ...
A team of researchers has uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics. Their study provides the first comprehensive understanding of how mRNA ...
Researchers from A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new method to study individual RNA ...
A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics ...
CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.
If machines can do this faster and more accurately than humans, is investing years in learning another language still worth ...
Engineered nanoparticles can improve cancer immunotherapy by delivering drugs, antigens, and genetic payloads with greater ...
Mirai Bio, the innovation delivery partner for companies developing next generation nucleic acid medicines, today announced new preclinical data from an oral presentation at the American Society of ...